Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

HIV Infection

Free Subscription 02.03.2026 13 AIDS 1 Blood 1 BMC Neurol 1 BMJ 9 Clin Infect Dis 3 HIV Med 7 J Acquir Immune Defic Syndr 1 J Clin Invest 1 J Med Virol 1 J Virol 1 JAMA 1 Lancet 2 Nature 2 Pediatr Infect Dis J 1 PLoS Med 9 PLoS One 1 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. PANG X, Tang K, He Q, Ma J, et al
   Longitudinal molecular network analysis in Guangxi: implications for HIV control.
   AIDS. 2026 Feb 23. doi: 10.1097/QAD.0000000000004474.
   PubMed         Abstract available
   
   
2. ENRIQUEZ CANTO Y
   Clinical composition of HIV/AIDS-related deaths during the COVID-19 pandemic: a nationwide natural experiment (2017-2024).
   AIDS. 2026 Feb 25. doi: 10.1097/QAD.0000000000004472.
   PubMed         Abstract available
   
   
3. PESSOA FS
   Brazil's historic achievement: WHO certification for eliminating mother-to-child transmission of HIV in a continental nation.
   AIDS. 2026;40:539-540.
   PubMed        
   
   
4. ZALESAK A, Schnure M, Forster R, Jones JL, et al
   Targeted cuts to Ryan White programs could raise HIV incidence by 8-17% in 30 US states and the District of Columbia.
   AIDS. 2026;40:536-538.
   PubMed         Abstract available
   
   
5. RUBIN LH, Chandra A, Alt J, Dastgheyb RM, et al
   N-acetyl-aspartyl-glutamate connects neuroinflammatory signatures to attention and working memory in people with HIV.
   AIDS. 2026;40:532-535.
   PubMed         Abstract available
   
   
6. TAO K, Tzou PL, Sahoo MK, Hare CB, et al
   HIV-1 subtype diversity trends in a Northern California cohort.
   AIDS. 2026;40:530-532.
   PubMed         Abstract available
   
   
7. GOODKIN K, Dorfman D
   Social cognition in people with HIV: a neglected cognitive domain?
   AIDS. 2026;40:525-529.
   PubMed        
   
   
8. SOUDEYNS H
   High risk of reacquisition of hepatitis C virus infection in people with HIV with continued risk behavior.
   AIDS. 2026;40:519-521.
   PubMed        
   
   
9. SUBIA P, Jiang X
   The impact of APOE epsilon4 on cognitive performance in adults with HIV: a systematic review and meta-analysis.
   AIDS. 2026 Feb 23. doi: 10.1097/QAD.0000000000004473.
   PubMed         Abstract available
   
   
10. LV J, Feng L, Gao L, Yin Z, et al
    Gray matter asymmetry alterations in perinatally HIV-exposed adolescents: evidence from structural neuroimaging.
    AIDS. 2026 Feb 23. doi: 10.1097/QAD.0000000000004467.
    PubMed         Abstract available
    
    
11. BARR E, Abuogi L, Lingwall M, Qian Q, et al
    Breastfeeding support for women with HIV: lactation consultant HIV-knowledge, attitudes, stigma, and tele-lactation experiences.
    AIDS. 2026 Feb 23. doi: 10.1097/QAD.0000000000004466.
    PubMed         Abstract available
    
    
12. CICCULLO A, Iannone V, Giacomelli A, Baldin G, et al
    Changes in cardiovascular and metabolic risk scores after switching to DOR/3TC/TDF, DTG/3TC or BIC/FTC/TAF: results from a multicenter Italian cohort.
    AIDS. 2026 Feb 23. doi: 10.1097/QAD.0000000000004468.
    PubMed         Abstract available
    
    
13. CRANE HM, Dai M, Fredericksen R, Drumright LN, et al
    Routine collection of patient-reported outcomes in HIV clinics: lessons learned after more than 130,000 assessments have been completed.
    AIDS. 2026 Feb 23. doi: 10.1097/QAD.0000000000004470.
    PubMed         Abstract available
    
    

    
    Blood

14. MAYNARD L, Starke CE, Poole NH, Rust BJ, et al
    Antigen-boosted CD4 CAR-T cells fail to expand or control viremia in multiple nonhuman primate models of HIV.
    Blood. 2026 Feb 24:blood.2025032142. doi: 10.1182/blood.2025032142.
    PubMed         Abstract available
    
    

    
    BMC Neurol

15. DIAZ MM, Harris MG, Koble JM, Copperthite K, et al
    Association between processing speed and segregation/integration of large-scale functional networks in middle-aged and older people living with HIV.
    BMC Neurol. 2026 Feb 25. doi: 10.1186/s12883-026-04749.
    PubMed        
    
    

    
    BMJ

16. WISE J
    HIV: Daily pill could help patients simplify complex treatment regimens.
    BMJ. 2026;392:s389.
    PubMed        
    
    

    
    Clin Infect Dis

17. PUGSLEY RA, Davis NL, Cope AB, Diesel JC, et al
    Is three really what we need? Relative effectiveness of benzathine penicillin G and doxycycline treatment regimens for late or unknown duration syphilis in 6 United States jurisdictions, 2016-2021.
    Clin Infect Dis. 2026 Feb 23:ciag099. doi: 10.1093.
    PubMed         Abstract available
    
    
18. MOHAREB AM, Boyd A
    Hepatitis B Virus Reactivation in People With HIV After Treatment With Non-hepatitis B virus-active Antiretroviral Therapy.
    Clin Infect Dis. 2026 Feb 24:ciag002. doi: 10.1093.
    PubMed        
    
    
19. SMITH AC, Kersh EN
    Evidence Review for Centers for Disease Control and Prevention Guidance Development on the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
    Clin Infect Dis. 2026;82.
    PubMed         Abstract available
    
    
20. SOGE OO, Reimche JL, Smith AC, Schmerer MW, et al
    Culture and Identification of Neisseria gonorrhoeae: A Narrative Review of Current Laboratory Methods.
    Clin Infect Dis. 2026;82.
    PubMed         Abstract available
    
    
21. STERKEL AK, Loya TJ, Smith AC, Southern T, et al
    Narrative Review of Chlamydia trachomatis Culture, Viability Testing, and Sequencing Methods.
    Clin Infect Dis. 2026;82.
    PubMed         Abstract available
    
    
22. MITCHELL KK, Smith AC, Ayala JC, Schmerer MW, et al
    Review of Methods for Detecting Antimicrobial Resistance of Neisseria gonorrhoeae.
    Clin Infect Dis. 2026;82.
    PubMed         Abstract available
    
    
23. MANABE YC, Smith AC, Trow S, Tran A, et al
    Point-of-care Tests for Chlamydia trachomatis and Neisseria gonorrhoeae: Review of the Literature.
    Clin Infect Dis. 2026;82.
    PubMed         Abstract available
    
    
24. CRUMPLER M, Realegeno SE, Shakir SM, Hutton SM, et al
    Review of the Performance of Laboratory-Based Molecular Diagnostics for Chlamydia trachomatis and Neisseria gonorrhoeae.
    Clin Infect Dis. 2026;82.
    PubMed         Abstract available
    
    
25. NELLORE A, Bajema K, Belden K, Blumberg D, et al
    IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal COVID-19 infections in immunocompromised patients.
    Clin Infect Dis. 2026 Feb 25:ciag115. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    HIV Med

26. CARUSO E, Tavelli A, De Bona A, Frattini N, et al
    Achieving reimbursable PrEP is insufficient to increase and diversify the users attending community-based services.
    HIV Med. 2026 Feb 22. doi: 10.1111/hiv.70209.
    PubMed         Abstract available
    
    
27. BENEDITTIS S, Tavelli A, Gagliardini R, Bini T, et al
    Peer-supported digital collection of patient-reported outcomes in HIV care: Promise, practical barriers and lessons from a pilot study within the ICONA cohort.
    HIV Med. 2026 Feb 25. doi: 10.1111/hiv.70214.
    PubMed         Abstract available
    
    
28. PURUSOTHMAN P, Barbisoni L, Leoni D, Sasset L, et al
    The outcomes of anxiety and depression symptom screening in a population with HIV: Insights from an HIV service in Northern Italy.
    HIV Med. 2026 Feb 27. doi: 10.1111/hiv.70211.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

29. SAH SS, Kumbhalwar A
    Comment on "Higher Acceptability of the Monthly Dapivirine Ring Versus Daily Oral Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women in Sub-Saharan Africa in the REACH Trial".
    J Acquir Immune Defic Syndr. 2026 Feb 23. doi: 10.1097/QAI.0000000000003851.
    PubMed        
    
    
30. DAVIS SM, Fellows I, de Leon O, Bastani P, et al
    Circumcision for HIV prevention in men who have sex with men: an updated meta-analysis.
    J Acquir Immune Defic Syndr. 2025 Dec 2:10.1097/QAI.0000000000003814.
    PubMed         Abstract available
    
    
31. KU C, Pothamsetty N, Lea AN, Alexeeff SE, et al
    Mammogram Rates Among Women with and without HIV in a Large Integrated Healthcare System.
    J Acquir Immune Defic Syndr. 2026 Feb 27. doi: 10.1097/QAI.0000000000003857.
    PubMed         Abstract available
    
    
32. O'SHEA J, Derton A, Henson J, Iqbal K, et al
    Real-World Uptake and Clinical Outcomes of Long-Acting Injectable Cabotegravir/rilpivirine in the United States, 2021-2023.
    J Acquir Immune Defic Syndr. 2026 Feb 26. doi: 10.1097/QAI.0000000000003855.
    PubMed         Abstract available
    
    
33. LEE M, Olson A, Pickering RT, Ieong MH, et al
    Alterations to the bronchial gene-expression effects of tobacco smoking in people living with HIV.
    J Acquir Immune Defic Syndr. 2026 Feb 24. doi: 10.1097/QAI.0000000000003853.
    PubMed         Abstract available
    
    
34. ANN SCHMIDT HM, Chan C, Ong J, Tieosapjaroen W, et al
    The "PrEP APPEAL" of less frequent dosing: acceptability of six-monthly long acting-injectable PrEP among gay and other men who have sex with men and transgender women in Asia.
    J Acquir Immune Defic Syndr. 2026 Feb 24. doi: 10.1097/QAI.0000000000003852.
    PubMed         Abstract available
    
    
35. HAIDAR L, Crane HM, Nance RM, Doupe MB, et al
    Impact of SGLT2 Inhibitors on Kidney Function Among People with HIV: A US Prospective Multi-Site Study.
    J Acquir Immune Defic Syndr. 2026 Feb 24. doi: 10.1097/QAI.0000000000003854.
    PubMed         Abstract available
    
    

    
    J Clin Invest

36. PAL PB, Elizaldi SR, Diniz GB, Rai RP, et al
    alpha4 integrin blockade impairs CD8 T cell neuroimmune surveillance following SIV infection.
    J Clin Invest. 2026 Feb 24:e198730. doi: 10.1172/JCI198730.
    PubMed         Abstract available
    
    

    
    J Med Virol

37. LOU Y, He X, Li G, Sikhondze M, et al
    CD4-Based Chimeric Antigen Receptor (CAR)-T Cells With Resistance to HIV-1 Infection and Enhanced Anti-HIV Efficacy: Covalent Interaction Between CD4-CAR and HIV-1 Envelope Glycoprotein.
    J Med Virol. 2026;98:e70853.
    PubMed         Abstract available
    
    

    
    J Virol

38. STERN J, Shepherd RA, Kim Y, Tumpach C, et al
    Methaneseleninic acid, a circadian-modulating agent, reactivates latent HIV-1 infection without cellular activation or proliferation.
    J Virol. 2026 Feb 25:e0198325. doi: 10.1128/jvi.01983.
    PubMed         Abstract available
    
    

    
    JAMA

39. SHORT WR, Sheth AN, Ciaranello A
    HIV During Pregnancy and Infant Feeding.
    JAMA. 2026 Feb 23. doi: 10.1001/jama.2026.0943.
    PubMed        
    
    

    
    Lancet

40. RATEVOSIAN J, Beyrer C
    Fundamental PEPFAR reform risks a period of structural vulnerability in the HIV response.
    Lancet. 2026 Feb 24:S0140-6736(26)00369-7. doi: 10.1016/S0140-6736(26)00369.
    PubMed        
    
    

    
    Nature

41. FERREIRA IATM, Herrera A, Huynh TT, Stone E, et al
    Dynamic antigen expression and cytotoxic T cell resistance in HIV reservoir clones.
    Nature. 2026 Feb 24. doi: 10.1038/s41586-026-10298.
    PubMed         Abstract available
    
    
42. GANESH L, Burstein E, Guha-Niyogi A, Louder MK, et al
    Editorial Expression of Concern: The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes.
    Nature. 2026 Feb 27. doi: 10.1038/s41586-026-10308.
    PubMed        
    
    

    
    Pediatr Infect Dis J

43. NATUKUNDA E, Szubert AJ, Bwakura-Dangarembizi M, Mulenga V, et al
    Body Composition Changes in Children Living With HIV Initiated on Dolutegravir or Protease Inhibitors in the CHAPAS-4 Trial.
    Pediatr Infect Dis J. 2026 Feb 24. doi: 10.1097/INF.0000000000005195.
    PubMed         Abstract available
    
    
44. USAKLIOGLU EROL M, Soguksu P, Kacmaz BB, Mese S, et al
    Uncovering the Hidden Players: Double-negative T Cells in Pediatric HIV and Their Impact on Disease Progression.
    Pediatr Infect Dis J. 2026 Feb 26. doi: 10.1097/INF.0000000000005199.
    PubMed         Abstract available
    
    

    
    PLoS Med

45. LI Q, Zhou J, Xu Y, Zou H, et al
    Medication adherence and its associated factors among oral pre-exposure prophylaxis (PrEP) users in China: The Real-world E-consumer Cohort of PrEP study.
    PLoS Med. 2026;23:e1004733.
    PubMed         Abstract available
    
    

    
    PLoS One

46. KLABBERS RE, Mugyenyi A, Nsubuga R, Asaba G, et al
    Protocol for Head StART: A hybrid type II cluster randomized controlled trial evaluating community ART delivery for people newly diagnosed with HIV in refugee settlements in Uganda.
    PLoS One. 2026;21:e0340916.
    PubMed         Abstract available
    
    
47. SYABBALO E, Mpisa S, Vinikoor MJ, Wamundila M, et al
    Hepatitis B immunity and vaccine completion among adults at increased risk for hepatitis B infection in Zambia.
    PLoS One. 2026;21:e0339690.
    PubMed         Abstract available
    
    
48. KOVTUN O, Cheshun O, Pashchuk O, Dumchev K, et al
    Mapping of sex work hotspots to guide targeted HIV prevention: Evidence from eight Ukrainian cities.
    PLoS One. 2026;21:e0343803.
    PubMed         Abstract available
    
    
49. ZHANG H, Wu P, Ye W
    HIV-1 drug resistance and associated risk factors in patients with antiretroviral therapy failure in Chongqing, China, 2019-2023.
    PLoS One. 2026;21:e0342301.
    PubMed         Abstract available
    
    
50. DAKPUI HD, Abu-Ba'are GR, Saaka MS, Boyd D, et al
    HIV self-testing awareness among African refugee male sex workers in Italy: A mixed-methods study.
    PLoS One. 2026;21:e0343441.
    PubMed         Abstract available
    
    
51. PYKALO I, Filippovych M, Zeziulin O, Dvoriak S, et al
    Holding the line: Provider and patient perspectives on Medications for Opioid Use Disorder continuity during the war in Ukraine.
    PLoS One. 2026;21:e0341182.
    PubMed         Abstract available
    
    
52. ZANI B, Fairall L, Petersen I, Folb N, et al
    Sociodemographic and health-related factors associated with viral load non-suppression and body mass index in adults with depression symptoms receiving antiretroviral therapy in South Africa.
    PLoS One. 2026;21:e0329990.
    PubMed         Abstract available
    
    
53. MOONGA G, Mwila F, Muchinga J, Malasha M, et al
    Anemia and its associated factors among women of reproductive Age in Zambia: A multilevel mixed-effects analysis.
    PLoS One. 2026;21:e0330400.
    PubMed         Abstract available
    
    
54. LIU Y, Liu J, Chang Y, Chen X, et al
    Knowledge, attitudes, and practices of healthcare providers in Beijing regarding human immunodeficiency virus and tuberculosis co-infection: A multicenter cross-sectional study.
    PLoS One. 2026;21:e0341132.
    PubMed         Abstract available
    
    

    
    Vaccine

55. HUDSON A, Borgetti S, Rick AM, Laurens MB, et al
    Impact of prior SARS-CoV-2 acquisition on binding and neutralizing antibody responses following COVID-19 vaccination: A cross-protocol analysis of individual-level data from six phase 3 clinical trials.
    Vaccine. 2026;77:128380.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum